BioRestorative Therapies, Inc. Balance Sheet
BRTX|14 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
BioRestorative Therapies, Inc. had $4M in total assets and $356,744 in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.5M | $547.9K | $884.4K | $1.7M | $21.0M | - | - | - | - | - | - | - | - | - |
| Accounts Receivable | $15.5K | $188.4K | $19.3K | $16.0K | $5.0K | $17.0K | $32.0K | $29.0K | $38.0K | $6.0K | $93.4K | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | $1.9K | $18.0K | $12.5K |
| Current Assets | $3.1M | $11.1M | $11.4M | $15.1M | $21.5M | $3.2M | $68.9K | $181.0K | $519.7K | $61.7K | $289.3K | $114.3K | $239.8K | $31.3K |
| PP&E (Net) | $358.8K | $362.9K | $356.1K | $261.0K | $38.0K | $21.9K | $68.4K | $175.2K | $327.8K | $508.6K | $643.1K | $493.9K | $35.6K | $59.4K |
| Total Assets | $4.1M | $12.3M | $12.6M | $16.4M | $22.5M | $4.3M | $1.5M | $1.2M | $1.8M | $1.6M | $2.0M | $1.7M | $1.4M | $1.3M |
| Current Liabilities | $3.7M | $3.7M | $2.6M | $440.3K | $363.8K | $1.0M | $13.7M | $9.3M | $8.4M | $5.8M | $5.6M | $8.5M | $7.5M | $2.8M |
| Total Debt | - | - | - | - | $250.0K | - | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $356.7K | $10.0M | $10.0M | $10.3M | $21.6M | -$12.8M | -$8.6M | -$6.8M | -$5.0M | -$3.9M | -$6.9M | -$6.7M | -$5.1M | -$51.1K |